INNOSPEC INC. (IOSP) Form 10-Q — Aug 5, 2026
Innospec's second-quarter 2026 net sales rose 12% year over year to $491.4 million from $439.7 million, with net income attributable to the company climbing to $30.8 million from $23.5 million and diluted EPS up 33% to $1.25 from $0.94. Growth was broad-based across segments: Performance Chemicals sales rose 9% to $190.3 million, Fuel Specialties rose 12% to $185.7 million, and Oilfield Services rose 14% to $115.4 million, with the oilfield segment lifted by its DRA plant expansion and a 2.7-point gross margin gain. The balance sheet remains net cash with $250.2 million in cash, no borrowings on its $250.0 million revolving credit facility, and total assets of $1,846.2 million.
Key figures
- Eps
- $1.25 diluted (Q2 2026) vs $0.94 prior year
- Revenue
- $491.4 million (Q2 2026); $944.6 million (H1 2026)
- Net Income
- $30.8 million attributable to Innospec (Q2 2026) vs $23.5 million; $61.2 million H1 2026
- Total Debt
- $0 — no borrowings outstanding under revolving credit facility
- Revenue Yoy
- +12% Q2 YoY; +7% H1 YoY
- Total Assets
- $1,846.2 million
- Cash Position
- $250.2 million at June 30, 2026 (vs $292.5 million at Dec 31, 2025)
- Shares Outstanding
- 24631047
- Buyback
- New $75 million three-year program announced May 7, 2026; $75.0 million remaining; $13.5 million repurchased in H1
- Capex h1
- $26.6 million
- Gross profit q2
- $138.3 million, +12% YoY; 28.1% gross margin
- Dividend paid h1
- $22.7 million ($0.84 per share semi-annual)
- Segment sales q2
- Performance Chemicals $190.3M (+9%), Fuel Specialties $185.7M (+12%), Oilfield Services $115.4M (+14%)
- Operating income q2
- $39.7 million vs $34.3 million prior year
- Effective tax rate q2
- 25.0% GAAP; 23.1% adjusted
- Operating cash flow h1
- $24.8 million vs $38.8 million prior year
- Plant closure provisions
- $64.7 million
- Revolving credit facility
- $250.0 million multicurrency facility, undrawn, available until May 30, 2028
Price after filing
Close on the filing date to close N calendar days later (from $85.48). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.